The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
S | Sensory organs | |
2
|
S03 | Ophthalmological and otological preparations | |
3
|
S03A | Antiinfectives | |
4
|
S03AA | Antiinfectives | |
5
|
S03AA07 | Ciprofloxacin |
| Active Ingredient |
|---|
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
| Document | Type | Information Source | |
|---|---|---|---|
| CILOXAN Eye drops, solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CILOXAN Ointment | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| CILOXAN Ophthalmic solution | MPI, US: SPL/Old | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.